ClinicalTrials.gov record
A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris
ClinicalTrials.gov ID: NCT02413346
Public ClinicalTrials.gov record NCT02413346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Open-label study will evaluate the safety of an approximate 1.5 mg/kg/day dose of oral sarecycline in the long-term treatment of participants with moderate to severe facial acne vulgaris.
Study identification
- NCT ID
- NCT02413346
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 490 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 19, 2015
- Primary completion
- Aug 25, 2016
- Completion
- Aug 25, 2016
- Last update posted
- Jan 31, 2019
2015 – 2016
United States locations
- U.S. sites
- 56
- U.S. states
- 23
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Actavis Investigational Study Site #206 | Mobile | Alabama | 36608 | — |
| Actavis Investigational Study Site #236 | Hot Springs | Arkansas | 71913 | — |
| Actavis Investigational Study Site #245 | Carlsbad | California | 92008 | — |
| Actavis Investigational Study Site #129 | Encino | California | 91436 | — |
| Actavis Investigational Study Site #209 | Fremont | California | 94538 | — |
| Actavis Investigational Study Site #147 | Sacramento | California | 95819 | — |
| Actavis Investigational Study Site #150 | San Diego | California | 92120 | — |
| Actavis Investigational Study Site #125 | San Diego | California | 92123 | — |
| Actavis Investigational Study Site #204 | San Diego | California | 92123 | — |
| Actavis Investigational Study Site #222 | Denver | Colorado | 80220 | — |
| Actavis Investigational Study Site #148 | Wheat Ridge | Colorado | 80033 | — |
| Actavis Investigational Study Site #226 | Clearwater | Florida | 33761 | — |
| Actavis Investigational Study Site #238 | Jupiter | Florida | 33458 | — |
| Actavis Investigational Study Site #249 | Miami | Florida | 33142 | — |
| Actavis Investigational Study Site #145 | Miami | Florida | 33175 | — |
| Actavis Investigational Study Site #211 | Miramar | Florida | 33207 | — |
| Actavis Investigation Study Site # 140 | North Miami Beach | Florida | 33162 | — |
| Actavis Investigational Study Site #151 | Orange | Florida | 32073 | — |
| Actavis Investigational Study Site #203 | Tampa | Florida | 33609 | — |
| Actavis Investigational Study Site #242 | Snellville | Georgia | 30078 | — |
| Actavis Investigational Study Site #124 | Boise | Idaho | 83704 | — |
| Actavis Investigational Study Site #106 | Chicago | Illinois | 60611 | — |
| Actavis Investigational Study Site #113 | South Bend | Indiana | 46617 | — |
| Actavis Investigational Study Site #213 | Louisville | Kentucky | 40202 | — |
| Actavis Investigational Study Site #217 | Rockville | Maryland | 20850 | — |
| Actavis Investigational Study Site #251 | Clarkston | Michigan | 48346 | — |
| Actavis Investigational Study Site #235 | Clinton Township | Michigan | 48038 | — |
| Actavis Investigational Study Site #227 | Fort Gratiot | Michigan | 48059 | — |
| Actavis Investigational Study Site #111 | Warren | Michigan | 48088 | — |
| Actavis Investigational Study Site #221 | Fridley | Minnesota | 55432 | — |
| Actavis Investigational Study Site #231 | Omaha | Nebraska | 68144 | — |
| Actavis Investigational Study Site #146 | New York | New York | 10016 | — |
| Actavis Investigational Study Site #208 | New York | New York | 10155 | — |
| Actavis Investigational Study Site #240 | Rochester | New York | 14623 | — |
| Actavis Investigational Study Site #230 | Stony Brook | New York | 11790 | — |
| Actavis Investigational Study Site #229 | Raleigh | North Carolina | 27612 | — |
| Actavis Investigational Study Site #149 | Gresham | Oregon | 97030 | — |
| Actavis Investigational Study Site #257 | Philadelphia | Pennsylvania | 19103 | — |
| Actavis Investigational Study Site #225 | Goodlettsville | Tennessee | 37072 | — |
| Actavis Investigational Study Site #128 | Knoxville | Tennessee | 37917 | — |
| Actavis Investigational Study Site #216 | Knoxville | Tennessee | 37922 | — |
| Actavis Investigational Study Site #109 | Nashville | Tennessee | 37215 | — |
| Actavis Investigational Study Site #223 | Arlington | Texas | 76011 | — |
| Actavis Investigational Study Site #252 | Arlington | Texas | 76011 | — |
| Actavis Investigational Study Site #220 | College Station | Texas | 77845 | — |
| Actavis Investigational Study Site #104 | Dallas | Texas | 75234 | — |
| Actavis Investigational Study Site #142 | Houston | Texas | 77004 | — |
| Actavis Investigational Study Site #105 | Houston | Texas | 77056 | — |
| Actavis Investigational Study Site #201 | Katy | Texas | 77494 | — |
| Actavis Investigational Study Site #223 | Pflugerville | Texas | 78660 | — |
| Actavis Investigational Study Site #101 | Plano | Texas | 75093 | — |
| Actavis Investigational Study Site #207 | San Antonio | Texas | 78218 | — |
| Actavis Investigational Study Site #212 | West Jordan | Utah | 84088 | — |
| Actavis Investigational Study Site #244 | Norfolk | Virginia | 23507 | — |
| Actavis Investigational Study Site #144 | Spokane | Washington | 99202 | — |
| Actavis Investigational Study Site #233 | Walla Walla | Washington | 99362 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02413346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 31, 2019 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02413346 live on ClinicalTrials.gov.